{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T18:09:18Z","timestamp":1778609358435,"version":"3.51.4"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018623","name":"Quanzhou City Science and Technology Program","doi-asserted-by":"publisher","award":["CQZ2024N0060272"],"award-info":[{"award-number":["CQZ2024N0060272"]}],"id":[{"id":"10.13039\/501100018623","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Eosinophilic granulomatosis with polyangiitis (EGPA) was a rare systemic vasculitis characterized by eosinophilia, asthma, and necrotizing vasculitis. Metabolic dysregulation had been shown to participate in the pathogenesis of autoimmune diseases, but the plasma metabolic profile of EGPA remained unclear. This work was designed to systematically characterize the plasma metabolomic profiles of EGPA patients, identify differential metabolites that distinguish EGPA from bronchial asthma (BA), and explore their potential as biomarkers for differential diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Ten patients with EGPA, ten patients with BA, and ten age- and gender-matched healthy controls (HCs) were enrolled. Untargeted metabolomics based on liquid chromatography\/mass spectrometry (LC\/MS) was performed to analyze the metabolic profiles of the three groups. Differential metabolites were identified using VIP\u2009&gt;\u20091 and P\u2009&lt;\u20090.05. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis was performed on the differential metabolites, with statistical significance defined as P\u2009&lt;\u20090.05.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 971 metabolites were differentially expressed between EGPA patients and HCs. KEGG pathway enrichment analysis identified 59 pathways, five of which were statistically significant (P\u2009&lt;\u20090.05): caffeine metabolism; valine, leucine and isoleucine biosynthesis; alanine, aspartate and glutamate metabolism; arginine and proline metabolism; and glyoxylate and dicarboxylate metabolism. Comparison of EGPA with BA patients revealed 161 altered metabolites and 102 enriched pathways, three of which were significant (P\u2009&lt;\u20090.05): caffeine metabolism, basal cell carcinoma, and Fc gamma R-mediated phagocytosis. Receiver operating characteristic (ROC) curve analysis demonstrated that 21 of the 24 metabolites identified from the five key EGPA-HC pathways exhibited strong diagnostic performance (area under the curve [AUC] &gt; 0.8). Four metabolites (cholesterol, 5-acetylamino-6-formylamino-3-methyluracil, 5-acetylamino-6-amino-3-methyluracil, and 3-methylxanthine) showed high diagnostic potential (AUC\u2009&gt;\u20090.8) for distinguishing EGPA from BA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study revealed, for the first time, a distinct plasma metabolic profile in EGPA patients, with key pathways and candidate biomarkers identified. The metabolites with high diagnostic efficacy (AUC\u2009&gt;\u20090.8) might serve as candidate diagnostic biomarkers for EGPA and its differentiation from BA. These observations provided novel insights into the metabolic basis of EGPA pathogenesis and might provide valuable references for the clinical management of this rare disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0343182","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T17:26:12Z","timestamp":1778606772000},"page":"e0343182","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of a diagnostic metabolomic fingerprint in plasma for eosinophilic granulomatosis with polyangiitis"],"prefix":"10.1371","volume":"21","author":[{"given":"Songsen","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4099-2409","authenticated-orcid":true,"given":"Yanfang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"issue":"4","key":"pone.0343182.ref001","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1055\/s-0038-1669454","article-title":"Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss)","volume":"39","author":"Y Nguyen","year":"2018","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"pone.0343182.ref002","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00002281-200201000-00003","article-title":"Churg-Strauss syndrome: update on recent developments","volume":"14","author":"WL Gross","year":"2002","journal-title":"Curr Opin Rheumatol"},{"issue":"8","key":"pone.0343182.ref003","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/art.1780330806","article-title":"The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis)","volume":"33","author":"AT Masi","year":"1990","journal-title":"Arthritis Rheum"},{"issue":"5","key":"pone.0343182.ref004","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/ageing\/afg076","article-title":"Montelukast-associated Churg-Strauss syndrome","volume":"32","author":"AB Michael","year":"2003","journal-title":"Age Ageing"},{"issue":"6","key":"pone.0343182.ref005","first-page":"63","article-title":"Clinical variants of Churg-Strauss eosinophilic vasculitis","volume":"85","author":"VT Komarov","year":"2007","journal-title":"Klin Med (Mosk)"},{"issue":"6","key":"pone.0343182.ref006","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1081-1206(10)60743-0","article-title":"Warning nonrespiratory symptoms in asthma: catastrophic abdominal involvement in a case of Churg-Strauss syndrome","volume":"98","author":"G Rolla","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"pone.0343182.ref007","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/978-3-319-47656-8_9","article-title":"Applications of Metabolomics in Cancer Studies","volume":"965","author":"EG Armitage","year":"2017","journal-title":"Adv Exp Med Biol"},{"issue":"10","key":"pone.0343182.ref008","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.3390\/ijms20102467","article-title":"Metabolomics of Type 1 and Type 2 Diabetes","volume":"20","author":"B Arneth","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"8","key":"pone.0343182.ref009","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/CIRCULATIONAHA.117.029468","article-title":"Metabolic predictors of incident coronary heart disease in women","volume":"137","author":"NP Paynter","year":"2018","journal-title":"Circulation"},{"issue":"15","key":"pone.0343182.ref010","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.3390\/ijms20153755","article-title":"Tear Metabolomics in Dry Eye Disease: A Review","volume":"20","author":"M Yazdani","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"12","key":"pone.0343182.ref011","article-title":"Metabolic Disturbances in Adult-Onset Still\u2019s Disease Evaluated Using Liquid Chromatography\/Mass Spectrometry-Based Metabolomic Analysis","volume":"11","author":"D-Y Chen","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"pone.0343182.ref012","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s13075-018-1712-y","article-title":"Metabolomic alterations associated with Beh\u00e7et\u2019s disease","volume":"20","author":"W Zheng","year":"2018","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"pone.0343182.ref013","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/thorax-2024-222910","article-title":"BTS\/NICE\/SIGN joint guideline on asthma: diagnosis, monitoring and chronic asthma management (November 2024) - summary of recommendations","volume":"80","year":"2025","journal-title":"Thorax"},{"issue":"4","key":"pone.0343182.ref014","doi-asserted-by":"crossref","first-page":"485","DOI":"10.32383\/appdr\/140075","article-title":"A pharmacometabonomics study to predict azathioprine (AZA)-induced myelotoxicity in patients with rheumatological disease","volume":"78","author":"yanfang lin","year":"2021","journal-title":"Acta Poloniae Pharmaceutica - Drug Research"},{"key":"pone.0343182.ref015","doi-asserted-by":"crossref","first-page":"1013959","DOI":"10.3389\/fendo.2022.1013959","article-title":"Metabolomics analysis of stool in rats with type 2 diabetes mellitus after single-anastomosis duodenal-ileal bypass with sleeve gastrectomy","volume":"13","author":"L Wang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"pone.0343182.ref016","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkn810","article-title":"HMDB: a knowledgebase for the human metabolome","volume":"37","author":"DS Wishart","year":"2009","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"pone.0343182.ref017","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11882-014-0445-5","article-title":"Metabolomics approach in allergic and rheumatic diseases","volume":"14","author":"R Scrivo","year":"2014","journal-title":"Curr Allergy Asthma Rep"},{"issue":"7","key":"pone.0343182.ref018","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1136\/annrheumdis-2014-206618","article-title":"Metabolomics for rheumatic diseases: has the time come?","volume":"74","author":"L Semerano","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"pone.0343182.ref019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140993","article-title":"Prognosis Biomarkers of Severe Sepsis and Septic Shock by 1H NMR Urine Metabolomics in the Intensive Care Unit","volume":"10","author":"M Garcia-Simon","year":"2015","journal-title":"PLoS One"},{"issue":"11","key":"pone.0343182.ref020","first-page":"979","article-title":"GABAergic dysfunction in major depressive disorder and related therapeutic interventions","volume":"18","author":"K Hashimoto","year":"2020","journal-title":"Curr Neuropharmacol"},{"issue":"15","key":"pone.0343182.ref021","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.3390\/molecules24152678","article-title":"An Updated Review on Pharmaceutical Properties of Gamma-Aminobutyric Acid","volume":"24","author":"D-H Ngo","year":"2019","journal-title":"Molecules"},{"key":"pone.0343182.ref022","doi-asserted-by":"crossref","first-page":"792711","DOI":"10.3389\/fimmu.2021.792711","article-title":"Altered Plasma Metabolic Profiles in Chinese Patients With Multiple Sclerosis","volume":"12","author":"F Yang","year":"2021","journal-title":"Front Immunol"},{"key":"pone.0343182.ref023","doi-asserted-by":"crossref","first-page":"886822","DOI":"10.3389\/fimmu.2022.886822","article-title":"Immunometabolism - The Role of Branched-Chain Amino Acids","volume":"13","author":"B Yahsi","year":"2022","journal-title":"Front Immunol"},{"issue":"14","key":"pone.0343182.ref024","doi-asserted-by":"crossref","first-page":"7389","DOI":"10.3390\/ijms22147389","article-title":"Disease Differentiation and Monitoring of Anti-TNF Treatment in Rheumatoid Arthritis and Spondyloarthropathies","volume":"22","author":"K Bogunia-Kubik","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"21","key":"pone.0343182.ref025","doi-asserted-by":"crossref","first-page":"11763","DOI":"10.3390\/ijms222111763","article-title":"P5C as an Interface of Proline Interconvertible Amino Acids and Its Role in Regulation of Cell Survival and Apoptosis","volume":"22","author":"M Chalecka","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"pone.0343182.ref026","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s40425-018-0466-z","article-title":"1-Pyrroline-5-carboxylate released by prostate Cancer cell inhibit T cell proliferation and function by targeting SHP1\/cytochrome c oxidoreductase\/ROS Axis","volume":"6","author":"Y Yan","year":"2018","journal-title":"J Immunother Cancer"},{"key":"pone.0343182.ref027","author":"X Du","year":"2025","journal-title":"Metabolomics and transcriptomics analysis reveal a regulatory role for glutamine metabolism in eosinophil activation. Am J Respir Crit Care Med"},{"key":"pone.0343182.ref028","doi-asserted-by":"crossref","first-page":"1036536","DOI":"10.3389\/fnut.2022.1036536","article-title":"Intestinal proline is a potential anti-allergy factor for allergy diagnosis and therapy","volume":"9","author":"J Ma","year":"2022","journal-title":"Front Nutr"},{"issue":"8","key":"pone.0343182.ref029","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.4049\/jimmunol.173.8.5298","article-title":"Gamma-aminobutyric acid inhibits T cell autoimmunity and the development of inflammatory responses in a mouse type 1 diabetes model","volume":"173","author":"J Tian","year":"2004","journal-title":"J Immunol"},{"issue":"5","key":"pone.0343182.ref030","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2217\/14622416.9.5.625","article-title":"Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms","volume":"9","author":"A Gunes","year":"2008","journal-title":"Pharmacogenomics"},{"issue":"1","key":"pone.0343182.ref031","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1124\/dmd.105.006528","article-title":"Modulation of CYP1A2 and CYP3A6 catalytic activities by serum from rabbits with a turpentine-induced inflammatory reaction and interleukin 6","volume":"34","author":"O Kourylko","year":"2006","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"pone.0343182.ref032","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.180","article-title":"Pharmacologic immunosuppression of mononuclear phagocyte phagocytosis by caffeine","volume":"3","author":"RP Steck","year":"2015","journal-title":"Pharmacol Res Perspect"},{"key":"pone.0343182.ref033","first-page":"635845","article-title":"Tricarboxylic acid (TCA) cycle intermediates: regulators of immune responses","volume":"12","author":"SM Riddle","year":"2021","journal-title":"Front Immunol"},{"key":"pone.0343182.ref034","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3389\/fimmu.2018.00141","article-title":"A Role for the Krebs Cycle Intermediate Citrate in Metabolic Reprogramming in Innate Immunity and Inflammation","volume":"9","author":"NC Williams","year":"2018","journal-title":"Front Immunol"},{"issue":"2","key":"pone.0343182.ref035","doi-asserted-by":"crossref","DOI":"10.1172\/JCI148552","article-title":"Lipid metabolism in autoimmune rheumatic disease: implications for modern and conventional therapies","volume":"132","author":"G Robinson","year":"2022","journal-title":"J Clin Invest"},{"issue":"13","key":"pone.0343182.ref036","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.3390\/nu16132070","article-title":"Association between Serum Lipids and Asthma in Adults-A Systematic Review","volume":"16","author":"A Ma\u0219taleru","year":"2024","journal-title":"Nutrients"},{"issue":"2","key":"pone.0343182.ref037","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/10600280211022281","article-title":"Impact of Interferons and Biological Drug Inhibitors of IL-2 and IL-6 on Small-Molecule Drug Metabolism Through the Cytochrome P450 System","volume":"56","author":"CM White","year":"2022","journal-title":"Ann Pharmacother"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0343182","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T17:26:19Z","timestamp":1778606779000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0343182"}},"subtitle":[],"editor":[{"given":"Saki","family":"Raheem","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0343182","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]}}}